{"id":52017,"date":"2024-03-23T17:26:53","date_gmt":"2024-03-23T17:26:53","guid":{"rendered":"https:\/\/medgyd.lt\/cc\/provenge-50x10x6-cd54lasteliu-250-ml-infuzine-dispersija-250-ml-n1-24510\/"},"modified":"2024-03-23T17:26:53","modified_gmt":"2024-03-23T17:26:53","slug":"provenge-50x10x6-cd54lasteliu-250-ml-infuzine-dispersija-250-ml-n1-24510","status":"publish","type":"post","link":"https:\/\/medgyd.lt\/cc\/provenge-50x10x6-cd54lasteliu-250-ml-infuzine-dispersija-250-ml-n1-24510\/","title":{"rendered":"Provenge 50&#215;10(x6) CD54+l\u0105steli\u0173\/250 ml infuzin\u0117 dispersija 250 ml N1"},"content":{"rendered":"<h1>Detali informacija apie Provenge 50&#215;10(x6) CD54+l\u0105steli\u0173\/250 ml<\/h1>\n<p>&nbsp;<\/p>\n<p><strong>Veiklioji med\u017eiaga:<\/strong> Autologin\u0117s vienbranduol\u0117s periferinio kraujo l\u0105stel\u0117s, aktyvuotos PAP-GM-CSF (Sipuleucel-T)<\/p>\n<p><strong>Veikliosios med\u017eiagos koncentracija:<\/strong> 50&#215;10(x6) CD54+l\u0105steli\u0173\/250 ml<\/p>\n<p><strong>Vartojimo b\u016bdas:<\/strong> leisti \u012f ven\u0105<\/p>\n<p><strong>Vaistinio preparato grup\u0117:<\/strong> Vaistinis preparatas<\/p>\n<p><strong>Kitos vaisto dozuot\u0117s: <\/strong>250 ml N1<strong><br \/>\n<\/strong><\/p>\n<p><strong>Vaistinio preparato pogrupis:<\/strong> Biologinis<\/p>\n<p><strong>Recepto poreikis:<\/strong> Receptinis<\/p>\n<p><strong>Preparato ATC kodas:<\/strong> L03AX17<\/p>\n<p><strong>Pakuot\u0117s tipas:<\/strong> mai\u0161elis<\/p>\n<p><strong>Dozuot\u0117 pakuot\u0117je:<\/strong> 250 ml N1<\/p>\n<p><strong>Vaisto stadija:<\/strong> I\u0161registruotas 2013-09-06 EU\/1\/13\/867\/001<\/p>\n<p><strong>Registruotojas: <\/strong>Dendreon UK Ltd..<\/p>\n<p><strong>Perregistravimo data: <\/strong><\/p>\n<p><strong>Registracijos \u0161alis: <\/strong>Jungtin\u0117 Karalyst\u0117<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Provenge sud\u0117tyje yra: Autologin\u0117s vienbranduol\u0117s periferinio kraujo l\u0105stel\u0117s, aktyvuotos PAP-GM-CSF (Sipuleucel-T) &#8211; 50&#215;10(x6) CD54+l\u0105steli\u0173\/250 ml infuzin\u0117 dispersija. Preparatas skirtas vartoti leisti \u012f ven\u0105. Receptinis preparatas. Pakuot\u0119 sudaro 250 ml N1 mai\u0161elis<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[69,14939,14940,4,5],"tags":[14944,14943,186,14942,14941,119],"class_list":["post-52017","post","type-post","status-publish","format-standard","hentry","category-biologinis","category-provenge","category-provenge-50x10x6-cd54lasteliu-250-ml","category-vaistai","category-vaistinis-preparatas-vaistai","tag-aktyvuotos-pap-gm-csf-sipuleucel-t","tag-autologines-vienbranduoles-periferinio-kraujo-lasteles","tag-biologinis","tag-infuzine-dispersija","tag-provenge","tag-receptinis"],"_links":{"self":[{"href":"https:\/\/medgyd.lt\/cc\/wp-json\/wp\/v2\/posts\/52017","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medgyd.lt\/cc\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medgyd.lt\/cc\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medgyd.lt\/cc\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/medgyd.lt\/cc\/wp-json\/wp\/v2\/comments?post=52017"}],"version-history":[{"count":0,"href":"https:\/\/medgyd.lt\/cc\/wp-json\/wp\/v2\/posts\/52017\/revisions"}],"wp:attachment":[{"href":"https:\/\/medgyd.lt\/cc\/wp-json\/wp\/v2\/media?parent=52017"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medgyd.lt\/cc\/wp-json\/wp\/v2\/categories?post=52017"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medgyd.lt\/cc\/wp-json\/wp\/v2\/tags?post=52017"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}